ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 128 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $930,954 | -9.2% | 36,437 | +1.9% | 0.00% | 0.0% |
| Q2 2023 | $1,025,654 | +140593.3% | 35,762 | +17.6% | 0.00% | 0.0% |
| Q1 2023 | $729 | +47.3% | 30,399 | +4.2% | 0.00% | 0.0% |
| Q4 2022 | $495 | -99.9% | 29,180 | +3.2% | 0.00% | 0.0% |
| Q3 2022 | $419,000 | +3.7% | 28,265 | +10.0% | 0.00% | 0.0% |
| Q2 2022 | $404,000 | -44.4% | 25,698 | -4.6% | 0.00% | 0.0% |
| Q1 2022 | $726,000 | -33.1% | 26,927 | -8.2% | 0.00% | 0.0% |
| Q4 2021 | $1,086,000 | -23.3% | 29,339 | -1.0% | 0.00% | -50.0% |
| Q3 2021 | $1,416,000 | +46.0% | 29,642 | +3.4% | 0.00% | +100.0% |
| Q2 2021 | $970,000 | +9.9% | 28,667 | +34.1% | 0.00% | 0.0% |
| Q1 2021 | $883,000 | -18.0% | 21,380 | -13.9% | 0.00% | 0.0% |
| Q4 2020 | $1,077,000 | +49.0% | 24,833 | +47.3% | 0.00% | 0.0% |
| Q3 2020 | $723,000 | -10.7% | 16,864 | -2.6% | 0.00% | 0.0% |
| Q2 2020 | $810,000 | – | 17,323 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |